share_log
Reuters ·  Mar 23 23:03
Clover Biopharmaceuticals - Announces U.S. Ind Clearance and Initiation of Revaccination Clinical Study for Rsv Vaccine Candidate Scb-1019 by US FDA
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 229

Recommended

Write a comment